SerpApi.Org
The U.S. Food and Drug Administration on Wednesday granted De Novo authorization for Johnson & Johnson’s JNJ OTTAVA Robotic Surgical System, marking the regulatory clearance of the world’s first table-integrated soft tissue robotic platform.
The marketing clearance encompasses multiple general surgery procedures.
The medical technology giant will initiate a commercial rollout with select U.S. facilities, prioritizing initial customer success while working to expand regulatory approvals and procedural indications globally.
An additional U.S. clinical study evaluating the platform for inguinal hernia procedures is currently underway.
Architecture And Space-Saving Design
Built to support modern operating room workflows, OTTAVA incorporates four robotic arms directly into the operating table.
The setup reduces the system’s physical footprint by 30% to 50% compared to conventional boom- or cart-mounted robotic systems, giving surgical personnel more space to move, communicate, and deliver care.
Advanced software controls coordinate the table-integrated arms to allow automated procedural setups.
A synchronized feature known as twin motion coordinates table and arm movements simultaneously, enabling patient repositioning and multi-quadrant surgical access without extensive manual adjustments.
Surgical Instruments And Digital Ecosystem
The platform includes updated surgical instrumentation, featuring monopolar curved scissors designed for complete cuts and a specialized two-in-one needle driver engineered to minimize accidental suture damage.
To support clinical teams, the system links to the secure Polyphonic digital ecosystem, which consolidates learning materials, media, and data-driven insights.
Additionally, a comprehensive training framework combining virtual, immersive, and hands-on instruction will assist clinicians in adopting the technology safely and effectively.
JNJ Stock Price Activity: Johnson & Johnson shares were up 2.00% at $255.61 at the time of publication on Wednesday, according to Benzinga Pro data.
Image via Shutterstock
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
This article FDA Approves Johnson & Johnson Table-Integrated OTTAVA Robotic Surgery System originally appeared on Benzinga.com.
